Iovance Biotherapeutics Inc (NASDAQ:IOVA)
| 36.72 Delayed Data As of Oct 22 |  -0.23 / -0.62%Today’s Change | 18.70 Today|||52-Week Range 41.49 | +32.66% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Year Trend | |||||
|---|---|---|---|---|---|---|
2015 | 2016 | 2017 | 2018 | |||
| Revenue and Income | Net Revenues | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Depreciation And Amortization | 999.0K | 978.0K | 952.0K | 956.0K | ||
| Operating Expenses | Gross Income | -999.0K | -978.0K | -952.0K | -956.0K | |
| General Expenses | 26.9M | 52.7M | 91.9M | 127.3M | ||
| Research And Development | 15.5M | 28.0M | 71.6M | 99.8M | ||
| Total Operating Expenses | 27.9M | 53.6M | 92.9M | 128.3M | ||
| Non-Operating Expenses | Operating Income | -27.9M | -53.6M | -92.9M | -128.3M | |
| Income Taxes, Minority Interest and Extra Items | Pre-Tax Income | -27.7M | -52.9M | -92.1M | -123.6M | |
| Preferred Dividend | 0.00 | -49.5M | -- | -- | ||
| Net Income | -27.7M | -52.9M | -92.1M | -123.6M | ||
| Shares To Calculate EPS | Shares To Calculate EPS | 44.4M | 55.3M | 65.2M | 97.3M | |
| Shares To Calculate EPS Diluted | 44.4M | 55.3M | 65.2M | 97.3M | ||
| Earnings Per Share | EPS | -$0.62 | -$1.85 | -$1.41 | -$1.27 | |
| EPS Diluted | -$0.62 | -$1.85 | -$1.41 | -$1.27 | ||
